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Abstract: The study deals with the assessment of patterns of left ventricular myocardial remodeling in adolescents with hypothalamic 
syndrome of puberty and arterial hypertension depending on endothelial nitric oxide synthase gene polymorphism in intron 4 (4b, 4a) 
and blood serum homocysteine level. 
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———————————————————— 
INTRODUCTION 
 
An increase in the number of younger patients with arterial 
hypertension (AH), which ranks high in the incidence and 
remains a significant medical and social challenge, has 
been observed recently [1-3]. Leading experts emphasize 
that determination of abnormal tendencies to the 
development of hypertension in adolescents, early 
diagnosis and correction of cardiovascular disorders exert a 
positive impact on the health of adults [4-8]. 
Hereditary factors have lately acquired certain significance 
among the causes of risk factors for hypertension and its 
complications. Mapped candidate genes, namely: 
angiotensin gene (AGT), angiotensin-converting enzyme 
gene (ACE) and endothelial nitric oxide synthase gene 
(eNOS) have become a prime focus for experts.AGT gene 
polymorphismis associated with high blood pressure in 
adults and left ventricular hypertrophy [9]. 
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Particular attention has recently been given to the study of 
complications resulting from hypertension, particularly 
impairment of the target organs (heart, blood vessels; 
potential risk factors for cardiovascular complications 
presently include hyperhomocysteinemia [10, 11]. 
The mechanisms of hypertension development in 
overweight adults are well understood. Adaptation and 
subsequent chronic compensatory hypofunction of the 
myocardium in patients with obesity leads to an increase in 
myocardial mass, which can enlarge due to hypertrophy of 
myocardiocytes. At the same time, the increase of the 
heart mass in patients with obesity can be associated with 
the increase in itscontent of fibrous tissue. Activation of 
myocardial fibrosis promotes an increase in the rigidity of 
the walls of the left ventricle reducing myocardial ability 
to relax, which triggers the development of diastolic 
dysfunction. Besides, myocardial fibrosis results in 
depletion of the vascular bed of the coronary arteries and 
a gradual decrease in myocardial contractility, remodeling 
of the left ventricle with subsequent development of 
circulatory failure [12,14]. 
Development of hypertension in adolescents has been 
actively studied [13]. Hypothalamic syndrome of puberty 
(HSP) is one of the diseases occurring in most patients with 
hypertension.  This syndrome basically involves impairment 
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of the system hypothalamus-hypophysis-peripheral 
endocrine organs with the development of insulin 
resistance with lipid metabolism shifts and progression of 
obesity. HSP is not a rare abnormality, but it is rarely 
diagnosed, therefore it is appropriate to study 
pathophysiological mechanisms underlying the formation of 
arterial hypertension in adolescents with HSP, presentation 
of metabolic disorders and methods of early diagnosis. 
In view of the above, early identification of changes in the 
cardiovascular system in adolescents with HSP is relevant 
in childhood, when the groundwork for disease 
development or preservation of health in adults isformed 
[10, 11]. 
 
2 PURPOSES, SUBJECTS AND METHODS:  
101 adolescents with HSP aged 14 to 17 years (average age 
15.8±0.66 years) were examined at Communal Health Pro-
tection Institution "Regional Children's Clinical Hospital" 
and Department of Pediatrics No.1 and Neonatology due to 
past history of high blood pressure episodes. 
The study involved assessment of case histories and 
presentation, physical development with waist measure-
ment (WM), hip measurement (HM), abdominal obesity 
(WM/HM ratio), and body mass index (BMI). The diagnosis 
was specified by 24-hour blood pressure monitoring (ABPM) 
using MD plus unit (Russia, Novosibirsk). The state of cardi-
ovascular system was evaluated by Doppler echocardiog-
raphy with standard technique recommended by the Asso-
ciation of Echocardiography [1]. 
Polymorphism of endothelial nitric oxide synthase gene 
was studied by polymerase chain reaction. Homocysteine 
level inblood serum in patients with different genotype 
was evaluated by immunoenzyme assay (ELISA). Statistical 
data processing was carried out using STATISTICA-6 soft-
ware with parametric and nonparametric methods. 
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3 RESULTS AND DISCUSSION 
The examination of 101 adolescents with hypothalamic 
syndrome of puberty showed the following genotypes: 
genotype 4b4b in 47 (46.53±4.99%) children, genotype 
4b4a in 43 (42.57±4.95%) adolescents and genotype 4a4a in 
11 (10.89±3.12%) teenagers. 
The relation of certain biochemical indices to patient’s 
genotype was assessed by a dispersive analysis version, 
namely Kruskall-Wallis test. 
The study revealed statistically reliable differences in a 
number of indices in patients with various genotypes, par-
ticularly insulin (p<0.05), homocysteine (p<0.001), triglyc-
erides (TG) (p<0.05),very low density lipoproteins(VLDL) 
(p<0.05), average systolic blood pressure during the 
night(ASPP(n)) (p<0.05), increase in the thickness of the 
posterior wall of the left ventricle in percent (%PWLV) 
(p<0.05), glomerular filtration rate (GFR) (p<0.05) (Table 
1). 
 
Table 1 
The metabolic and structurally functional indicators 
depending on the genotype. 
 
 
(Note:Me- median, LQ- lower quartile, UQ- upper quartile; 
TG-, triglycerides, VLDL- very low density lipoproteins; 
ASBP(n)- average systolic blood pressure during the night; 
GFR- glomerular filtration rate. P-  between groups of the 
genotypes 4a4a, 4b4b.) 
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Thus, patients with genotype 4a4a were found to have the 
highest level of insulin in blood serum and dyslipidemia; 
besides, patients-carriers of allele a were more frequently 
diagnosed with signs of myocardial remodeling with in-
volvement of the posterior wall of the left ventricle. 
Patients with genotype 4b4b were shown to have the high-
est indices of average systolic blood pressure during the 
night. Genotype 4b4a is perhaps an average version be-
tween the previous two genotypes. 
Thus, it is possible to assume that allele influence and, in 
particular, the most "unfavorable” genotype 4a4a, is medi-
ated through a number of metabolic disorders, resulting in 
the progression of atherosclerosis, endothelial dysfunction 
and myocardial remodeling of the left ventricle.  
Interesting data were obtained in the analysis of homocys-
teine levels in blood serum of patients with different geno-
type. The study showed the following findings: in patients 
with genotype 4b4b its level amounted Me = 11.8 [6.9; 
17.3] mcmole/l. In children with genotype 4b4a it com-
prised Me = 12.2 [7.9; 19.3] mcmole/l. In the group of 
adolescents with genotype 4a4a the level of homocysteine 
was Me = 2.9 [2.5; 4.6] mcmole/l.  
Thereafter, the patients were divided into 4 groups accord-
ing tocluster 1, 2, 3 or 4, that is by the level of homocyste-
ine in blood serum (Table2). 
 
Table 2. 
The level of homocysteine in the blood serum of pa-
tients carried to different, clusters mcmole / l. 
 
 
Note: 
Me- median, LQ- lower quartile, UQ- upper quartile. 
 
Thus, the first cluster included 11 adolescents with the 
lowest content of homocysteine in blood (2.43 ± 0.31 
µmol/l). The second cluster (n = 34) comprised patients 
with the level of homocysteine corresponding to normal 
indices (6.65 ± 1.94 µmol/l). The third cluster involved 38 
patients with the increased level of homocysteine in blood 
serum (13.68 ± 2.45 µmol/l). The fourth cluster consisted 
of 18 children with high level of homocysteine (29.56 ± 
8.42 µmol/l). 
Assessment of the heart remodeling variants according to 
the level of homocysteine showed that in the group of 
children with normal and increased homocysteine level the 
myocardial mass index of the left ventricle (LV) was within 
the normal range, while the relative thickness of LV wall 
tended to increase.The patients with the highest level of 
homocysteine were found to have a significantly reliable 
enlargement of the relative thickness of LV wall (p <0.05) 
and an increase in the myocardial mass index of the left 
ventricle (p <0.05). 
The study showed that progression of hyperhomocyste-
inemia was accompanied by an increase in the incidence of 
restrictive diastolic LV dysfunction as compared to adoles-
cents with normal blood serum homocysteine level (p 
<0.05). 
 
Fig. 1.The frequency of diastolic dysfunction in chil-
dren with different levels of homocysteine in the serum. 
 
 
Thus, an increase in blood serum homocysteine level influ-
ences the development of LV myocardial remodeling. In 
normal homocysteine level myocardial geometry is within 
normal range, whereas an increase in homocysteine level 
results in the development of concentric remodeling and-
concentric hypertrophy of LV myocardium in children with 
the highest level of homocysteine, which reflects regulari-
ties of LV myocardium remodeling. 
We investigated blood serum homocysteine level in adoles-
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cents with different ENOS genotype. The most obvious 
differences between the indices of homocysteine in blood 
serum were observed between patients with 4a4a and 4b4b 
genotypes. 
The nature of these distinctions was clarified by identifica-
tion of alleles a and b as a sign of "GROUP" sample stratifi-
cation, as well as by regression analysis in the subgroup of 
patients with allele a (hereafter - Group A) separately and 
in the subgroup of patients with allele b (hereafter- Group 
B). 
Thus, the study showed that patients-carriers of allele b 
with the growth of body mass and progression of abdominal 
obesity (WM/HM ratio) were more likely to have an in-
crease in the level of homocysteine in blood serum. It 
promoted progression of hypertension in this cohort of 
patients. Blood pressure stabilization was rather associated 
with the involvement of kidneys.The growth of body mass 
increased the volume of circulating blood and viscosity of 
blood. Moreover, fatty tissue might release angiotensino-
gen which resulted in dysfunction of kidneys, responsible 
for the long-term regulation of blood pressure by changing 
the activity of RAAS and sodium-volume-dependent sys-
tems. Hyperhomocysteinemia itself, as was stated above, 
promoted myocardial remodeling of the left ventricle. 
Thus, patients-carriers of allele b, were found to have a 
decreased cavity of LV myocardium (concentric remodel-
ing). It was reflected by sphericity index rateswhich as 
well as the height of the left ventricle decreased in hyper-
homocysteinemia progression. 
The results for group A regression are shown in Fig. 2. Indi-
ces of average diastolic blood pressure during the day and 
night and average systolic blood pressure during the day 
and night should be considered the most influential in 
prognosis of homocysteine level in blood serum for allele a 
carriers. 
Progression of arterial hypertension in this cohort of pa-
tients was associated with a change of vascular tone.As 
was mentioned above, destabilization of vascular wall in 
genotype 4a4a was influencedby the altered levels of tri-
glycerides, lipoproteins of very low density and hyperinsu-
linemia. 
  
regression results for a dependent variable: HOMO 
(tabl_natali_HOMOx3.sta) R= .64386623 R2= .41456372 
Correct. R2= .37348048 F(8.114)=10.091 p<.00000 Standart 
error of estimate: 8.7864 
  beta SE,β B SE, B t(114) p-level 
      -38,113 13,491 -2,825 0,006 
SADD -0,564 0,174 -0,629 0,194 -3,248 0,002 
DADD 0,706 0,139 1,021 0,201 5,070 0,000 
SADN 0,586 0,166 0,651 0,185 3,519 0,001 
DADN -0,562 0,158 -0,748 0,211 -3,544 0,001 
 
Fig. 2.The summary table of model of linear regression 
for group A when calculating in statistical environment 
to the STATISTICA. 
Note: SADD- average systolic blood pressure during the 
day, DADD - the average diastolic blood pressure during 
the day, SADN - average systolic blood pressure during the 
night, DADN- the average diastolic blood pressure during 
the night, VrSD - variability of systolic blood pressure 
during the day, VrSN- variability in systolic blood pressure 
overnight, TZS2 - the thickness of the back wall of the left 
ventricle in diastole, OTS - relative wall thickness of the 
left ventricle. 
 
Literature data confirm that nitrogen oxide production is 
decreased in patients-carriers of allele a [15-17], triggering 
endothelial dysfunction. In progression of arterial hyper-
tension and hyperhomocysteinemia these patients develop 
an increase in the thickness of left ventricular posterior 
wall and relative thickness of left ventricular wall – an 
integral indicator of myocardial LV remodeling, which is 
the most typical for concentric hypertrophy of LV myocar-
dium. 
Thus, hypothalamic syndrome of puberty is a disorder in 
children, which develops with arterial hypertension, ab-
dominal type of obesity, disruption of lipid range of blood, 
hyperinsulinemia. Considering the metabolic essence of 
HSPas a "prototype" of metabolic syndrome in adults, it is 
possible to consider that patients with HSP in adulthood 
are likely to develop cardiovascular impairments. If meta-
bolic disorders typical for HSP have a significant effect on 
vascular endothelium, in future it will ultimately result in 
endothelial dysfunction, myocardial LV remodeling, devel-
opment of diastolic and systolic dysfunction. 
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4  CONCLUSIONS 
1. The increased blood serum homocysteine level (≥10.40 
µmol/l) and high homocysteine level (≥21.0 µmol/l) in 
adolescents is associated with hypothalamic syndrome of 
puberty with signs of myocardial remodeling and diastolic 
function of the left ventricle. Progression of hyperhomo-
cysteinemia results in a decrease in indices of LV cav-
itysphericity. 
2. Assessment of endothelial nitric oxide synthase (eNOS) 
gene polymorphism in adolescents with hypothalamic syn-
drome of puberty determined genotype 4b/4b in 47% of 
children, genotype 4b/4a in 43%, genotype 4a/4a in 11% of 
adolescents. Genotype 4a4a is unfavorable concerning the 
development of metabolic disorders and is characterized 
by the highest level of immunoreactive insulin in blood 
serum (33.2 (16.5; 40.1) uIU/mL), an increased level of 
triglycerides (1.41 (1.18; 1.64) mmol/l). 
3. Adolescents with hypothalamic syndrome of puberty, 
accompanied by arterial  hypertension with different eNOS 
genotypes, who carry allele b typically develop concentric 
remodeling (p <0.05), whereascarriers of allele aundergo 
remodeling of a left ventricular myocardium by the type of 
concentric hypertrophy. 
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РЕЗЮМЕ 
Гончарь М.О., Коновалова Н.В., Муратов Г.Р. 
МЕХАНІЗМИ РЕМОДЕЛЮВАННЯ МІОКАРДУ У ПІДЛІТКІВ 
З ГІПОТАЛАМІЧНИМ СИНДРОМОМ ПУБЕРТАТНОГО 
ПЕРІОДУ ТА АРТЕРІАЛЬНОЮ ГІПЕРТЕНЗІЄЮ 
Харківський національний медичний університет 
 
Авторами вивчені моделі ремоделювання міокарда 
лівого шлуночка у підлітків із гіпоталамічним синдромом 
пубертатного періоду та артеріальною гіпертензією в 
залежності від поліморфізма гена ендотеліальної синта-
зи оксиду азоту в інтроні 4 (4b,4a) та рівня гомоцистеїну 
сироватки крові. 
 
Ключові слова: поліморфізм гена, ендотеліальна NO-
синтаза, гомоцистеїн, підлітки, ремоделювання міокар-
да, артеріальна гіпертензія. 
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Авторами изучены модели ремоделирования миокар-
да левого желудочка у подростков с гипоталамическим 
синдромом пубертатного периода и артериальной ги-
пертензией в зависимости от полиморфизма гена эндо-
телиальной синтазы оксида азота в интроне 4 (4b,4a) и 
уровня гомоцистеина сыворотки крови. 
 
Ключевые слова: полиморфизм гена, эндотелиаль-
ная NO-синтаза, гомоцистеин, подростки, ремоделиро-
вание миокарда, артериальная гипертензия. 
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